Medicine
Potassium chloride 20 mEq extended-release tablet
Potassium chloride 20 mEq extended-release tablet is a generic prescription medicine for oral use, made by 8 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 25°C (77°F), excursions permitted to 15° to 30°C (59° to 86°F)…
Key facts
- Active ingredient (INN)
- Potassium chloride
- Brand
- Sold under the generic name
- Strength
- 20 mEq
- Dosage form
- Extended-release tablet
- Route
- Oral
- Packs
- 100 tablets, 500 tablets, 1000 tablets and 22 more
- Manufacturers
- LupinIndiaSun Pharmaceutical IndustriesIndiaPD-Rx PharmaceuticalsProficient RxA-S Medication SolutionsActavis PharmaAmerican Health PackagingMajor Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store at 25°C (77°F), excursions permitted to 15° to 30°C (59° to 86°F). Storage Conditions: Keep tightly closed.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A12BA01 Potassium chloride
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 10 April 2002
- Identifiers
- RxCUI 1801294, 1801298DailyMed set ID 0a1f2f64-3b0b-5e5c-e063-6294a90a7185, 61daa681-05a0-4b2f-a6d0-c6fc1044f521, 47a87fb6-5e61-41c9-b759-10f7c74a67ce +5NDC 63304-987, 82804-075, 72789-365 +5Application ANDA076368, ANDA075604, ANDA206347
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet, extended release in 1 bottle | 43386-917-01 | LupinIndia | 21 January 2016 |
| 500 tablet, extended release in 1 bottle | 43386-917-05 | LupinIndia | 30 January 2017 |
| 1000 tablet, extended release in 1 bottle | 43386-917-10 | LupinIndia | 30 January 2017 |
| 100 tablet, extended release in 1 bottle | 63304-987-01 | Sun Pharmaceutical IndustriesIndia | 14 November 2023 |
| 500 tablet, extended release in 1 bottle | 63304-987-05 | Sun Pharmaceutical IndustriesIndia | 14 November 2023 |
| 1000 tablet, extended release in 1 bottle | 63304-987-10 | Sun Pharmaceutical IndustriesIndia | 14 November 2023 |
| 100 tablet, extended release in 1 bottle, plastic | 62037-720-01 | Actavis Pharma | 10 April 2002 |
| 1000 tablet, extended release in 1 bottle, plastic | 62037-720-10 | Actavis Pharma | 10 April 2002 |
| 30 tablet, extended release in 1 bottle | 50090-8163-0 | A-S Medication Solutions | 21 October 2026 |
| 60 tablet, extended release in 1 bottle | 50090-8163-1 | A-S Medication Solutions | 21 October 2026 |
| 90 tablet, extended release in 1 bottle | 50090-8163-2 | A-S Medication Solutions | 21 October 2026 |
| 80 blister pack in 1 carton / 1 tablet, extended release in 1 blister pack | 60687-756-09 | American Health Packaging | 26 January 2024 |
| 100 blister pack in 1 carton / 1 tablet, extended release in 1 blister pack | 0904-7548-61 | Major Pharmaceuticals | 4 February 2026 |
| 100 tablet, extended release in 1 bottle, plastic | 72789-365-01 | PD-Rx Pharmaceuticals | 4 December 2023 |
| 30 tablet, extended release in 1 bottle, plastic | 72789-365-30 | PD-Rx Pharmaceuticals | 28 December 2023 |
| 60 tablet, extended release in 1 bottle, plastic | 72789-365-60 | PD-Rx Pharmaceuticals | 19 January 2024 |
| 500 tablet, extended release in 1 bottle, plastic | 72789-365-82 | PD-Rx Pharmaceuticals | 14 November 2023 |
| 90 tablet, extended release in 1 bottle, plastic | 72789-365-90 | PD-Rx Pharmaceuticals | 19 January 2024 |
| 1000 tablet, extended release in 1 bottle, plastic | 72789-365-95 | PD-Rx Pharmaceuticals | 28 December 2023 |
| 3 tablet, extended release in 1 bottle, plastic | 82804-075-03 | Proficient Rx | 12 February 2024 |
| 6 tablet, extended release in 1 bottle, plastic | 82804-075-06 | Proficient Rx | 12 February 2024 |
| 10 tablet, extended release in 1 bottle, plastic | 82804-075-10 | Proficient Rx | 12 February 2024 |
| 30 tablet, extended release in 1 bottle, plastic | 82804-075-30 | Proficient Rx | 12 February 2024 |
| 60 tablet, extended release in 1 bottle, plastic | 82804-075-60 | Proficient Rx | 12 February 2024 |
| 90 tablet, extended release in 1 bottle, plastic | 82804-075-90 | Proficient Rx | 12 February 2024 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 25 April 1975 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Potassium chloride
Clinical summary
Potassium chloride is an osmotic laxative indicated for the treatment and prophylaxis of hypokalemia with or without metabolic alkalosis, in patients for whom dietary management with potassium-rich foods or diuretic dose reduction is insufficient. MedsAcross supplies Potassium chloride for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Potassium chlorideFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- KLOR-CON prescribing information (Upsher-Smith Laboratories) · U.S. National Library of Medicine, DailyMed
Need Potassium chloride 20 mEq extended-release tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.